Results 101 to 110 of about 30,754 (246)

Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants

open access: yesClinical and Translational Science, Volume 19, Issue 11, November 2026.
ABSTRACT Elunetirom (ABX‐002) is a brain‐targeted, oral prodrug being developed for the adjunctive treatment of major depressive disorder and bipolar depression. The active moiety, LL‐340001, is a thyroid hormone receptor agonist with modest selectivity for beta over alpha thyroid hormone receptors. Upon entering the brain, the intended site of action,
Jason R. Harris   +11 more
wiley   +1 more source

Levothyroxine [PDF]

open access: yesVnitřní lékařství, 2022
openaire   +1 more source

Levothyroxine intoxication: Scientific letter [Levotiroksin i?ntoksikasyonu]

open access: yes, 2007
Levothyroxine is presently dominant agent prescribed for thyroid hormone replacement; it account for 75% of all prescriptions for thyroid hormone products.
Gürsoy S.   +5 more
core  

Evaluation of thyroglobulin autoantibodies in dogs at the time of diagnosis of hypoadrenocorticism and during treatment

open access: yesVeterinary Record, Volume 199, Issue 8, Page e350-e358, 17/24 October 2026.
Abstract Background Autoimmune thyroiditis (AIT) may occur more frequently in dogs with hypoadrenocorticism (HA) than previously recognised. The objective of this study was to determine the presence of thyroglobulin autoantibodies (TgAAs) in dogs with HA.
Christin Emming   +6 more
wiley   +1 more source

Levothyroxine versus Levothyroxine with Iodine in Reduction of Thyroid Nodule Volume: A Double-Blind Randomized Controlled Trial

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2019
Objective: To compare levothyroxine alone and in combination with iodine on thyroid nodule volume reduction. Methods:           Design:           Double-Blind Randomized Controlled Trial           Setting:           Tertiary Government ...
Donnie Jan D. Segocio   +1 more
doaj   +1 more source

The Homozygous p.(Arg215Ter) Variant in XRCC2 Is Associated With Atypical Fanconi Anemia Without Major Hematological Abnormalities in Childhood

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2331-2337, October 2026.
ABSTRACT Fanconi Anemia (FA) is the most frequent inherited bone marrow failure syndrome. A role for the XRCC2 gene in FA was suspected in 2012 and confirmed in 2016, but only two affected individuals have been described thus far, and no long‐term follow‐up is available.
Sabina Cenciarelli   +11 more
wiley   +1 more source

A severe case of levothyroxine intoxication successfully treated in intensive care unit

open access: yes, 2018
Levothyroxine intoxication is a rare clinical entity which is usually asymptomatic. However, severe symptoms such as respiratory failure, malignant hyperthermia, seizures, arrhythmia, and coma have been reported.
Merve Keskinkilic   +5 more
core   +1 more source

Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3586-3597, October 2026.
Aim Many women take medications during pregnancy. However, the risk to the fetus from most medications is uncertain. Congenital anomalies are one of the leading causes of infant death and contribute to long‐term disability. Signal detection methods can be used to systematically identify possible medication–anomaly associations that require further ...
Hannah Johnson   +22 more
wiley   +1 more source

Liquid and softgel levothyroxine use in clinical practice: state of the art

open access: yes, 2016
Levothyroxine is recognized as the treatment of choice for hypothyroidism. So far, the tablet levothyroxine has been the formulation almost exclusively used, even though an optimal daily dose of levothyroxine has been unsuccessfully sought and a ...
CENTANNI, Marco   +3 more
core   +1 more source

Effect of levothyroxine plus liothyronine combination therapy on hypothyroid patients quality of life [PDF]

open access: yes, 2020
BackgroundLiothyronine combination with Levothyroxine(T4-T3) has been tried to improve the quality of life among hypothyroid patients on levothyroxine immunotherapy and normal thyroxine stimulating hormone levels.
Eyad Muwaffaq Alsaqqa; Internal Medicine Resident, King Salman Armed Forced Hospital, Tabuk, Saudi Arabia   +7 more
core  

Home - About - Disclaimer - Privacy